MEDICINES CO's ticker is and the CUSIP is 584688AE5. A total of 41 filers reported holding MEDICINES CO in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,102,000 | +73.8% | 10,000,000 | +42.9% | 0.61% | -3.2% |
| Q1 2019 | $6,964,000 | +13.9% | 7,000,000 | 0.0% | 0.63% | -51.9% |
| Q4 2018 | $6,112,000 | -66.5% | 7,000,000 | -53.3% | 1.30% | -48.6% |
| Q2 2018 | $18,240,000 | +5.4% | 15,000,000 | 0.0% | 2.53% | +63.6% |
| Q1 2018 | $17,301,000 | -45.5% | 15,000,000 | -50.0% | 1.55% | -50.6% |
| Q4 2017 | $31,721,000 | +25.5% | 30,000,000 | +50.0% | 3.13% | +27.5% |
| Q3 2017 | $25,268,000 | +29.4% | 20,000,000 | +33.3% | 2.46% | +80.2% |
| Q2 2017 | $19,520,000 | -1.2% | 15,000,000 | +20.0% | 1.36% | -7.1% |
| Q1 2017 | $19,763,000 | -40.2% | 12,500,000 | -54.5% | 1.47% | -36.0% |
| Q4 2016 | $33,069,000 | +104.4% | 27,500,000 | +120.0% | 2.29% | +122.9% |
| Q3 2016 | $16,175,000 | -46.4% | 12,500,000 | -51.0% | 1.03% | -60.7% |
| Q2 2016 | $30,177,000 | -11.2% | 25,500,000 | -15.0% | 2.62% | -19.9% |
| Q1 2016 | $33,984,000 | – | 30,000,000 | – | 3.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 27,450,000 | $35,755,000 | 1.51% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,886,000 | $11,559,000 | 1.51% |
| Myriad Asset Management Ltd. | 15,000,000 | $19,520,000 | 1.36% |
| TFG Asset Management GP Ltd | 5,000,000 | $6,601,000 | 0.98% |
| Castle Creek Arbitrage, LLC | 6,000,000 | $7,823,000 | 0.84% |
| WOLVERINE ASSET MANAGEMENT LLC | 47,410,000 | $61,720,000 | 0.78% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 19,935,000 | $26,002,000 | 0.71% |
| Weiss Asset Management LP | 5,000,000 | $6,610,000 | 0.68% |
| AQR Arbitrage LLC | 40,800,000 | $53,219,000 | 0.58% |
| Opera Trading Capital | 2,500,000 | $3,291,000 | 0.58% |